Low level of hepatitis B viremia compared with undetectable viremia increases the risk of hepatocellular carcinoma in patients with untreated compensated cirrhosis.
Jiwon YangWon-Mook ChoiJu Hyun ShimDanbi LeeKang Mo KimYoung-Suk LimHan Chu LeeJonggi ChoiPublished in: The American journal of gastroenterology (2023)
Compared with patients with undetectable HBV DNA, those with compensated cirrhosis and LLV had a significantly higher risk of HCC. Antiviral treatment should be advised for these patients.